Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007
Author(s) -
Carmen Ardanuy,
Fé Tubau,
Román Pallarés,
Laura Calatayud,
M.Á. Domínguez,
Dora Rolo,
Inmaculada Grau,
R. Russell Martin,
Josefina Liñares
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/594125
Subject(s) - pneumococcal conjugate vaccine , medicine , population , incidence (geometry) , pediatrics , streptococcus pneumoniae , environmental health , antibiotics , physics , optics , microbiology and biotechnology , biology
A dramatic decrease in the incidence of invasive pneumococcal disease (IPD) was observed among children and adults in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). Little is known about the incidence of IPD after PCV7 licensure in Europe. The objective of this study was to examine changes in the prevalence of IPD among adults in the PCV7 era.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom